Prediction of coronary atherosclerosis progression in type 2 diabetes mellitus based on AI-derived CCTA parameters and clinical factors: a follow-up study

IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Ling Ma, Yangyang Li, Xiaojie Xie, Xiao Cui, Shaolei Kang, Dan Han, Wen Zhao
{"title":"Prediction of coronary atherosclerosis progression in type 2 diabetes mellitus based on AI-derived CCTA parameters and clinical factors: a follow-up study","authors":"Ling Ma,&nbsp;Yangyang Li,&nbsp;Xiaojie Xie,&nbsp;Xiao Cui,&nbsp;Shaolei Kang,&nbsp;Dan Han,&nbsp;Wen Zhao","doi":"10.1007/s00592-026-02761-x","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To develop a predictive model for coronary atherosclerosis progression in patients with type 2 diabetes mellitus (T2DM) based on Artificial intelligence(AI)-derived coronary computed tomography angiography (CCTA) parameters combined with clinical indicators.</p><h3>Methods</h3><p>This retrospective study enrolled 114 patients with T2DM and non-obstructive coronary artery disease (1%–49% stenosis) who underwent CCTA at our hospital between September 2019 and September 2024. After follow-up of 1–5 years, patients were stratified into a progression group (<i>n</i> = 48) and a control group (<i>n</i> = 66). Progression was defined as the occurrence of acute myocardial infarction, revascularization, or stenosis progression to ≥ 50% on follow-up CCTA. Clinical data and AI-derived quantitative parameters of pericoronary adipose tissue(PCAT) and coronary plaques were compared. A predictive model was then developed using stepwise logistic regression and its performance evaluated.</p><h3>Results</h3><p>The progression group had significantly higher glycated hemoglobin (HbA1c) and troponin, and lower high-density lipoprotein cholesterol (HDL-C) (all <i>P</i> &lt; 0.05).CCTA analysis revealed that the progression group had a significantly greater pericoronary fat attenuation index around the left anterior descending (LAD-FAI) and left circumflex (LCX-FAI) arteries, as well as increased plaque length, total plaque volume, and specific plaque component volumes (all <i>P</i> &lt; 0.05). Multivariate logistic regression analysis identified HbA1c, LAD-FAI, and plaque length as independent predictors of progression. A nomogram based on these predictors achieved an AUC of 0.8332.</p><h3>Conclusion</h3><p>LAD-FAI and plaque length and HbA1c are independent predictors for the progression of non-obstructive coronary lesions in T2DM patients. The proposed nomogram may provide a noninvasive and cost-effective tool for early risk stratification and preventive management.</p></div>","PeriodicalId":6921,"journal":{"name":"Acta Diabetologica","volume":"63 10","pages":"1783 - 1795"},"PeriodicalIF":3.1000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Diabetologica","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00592-026-02761-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To develop a predictive model for coronary atherosclerosis progression in patients with type 2 diabetes mellitus (T2DM) based on Artificial intelligence(AI)-derived coronary computed tomography angiography (CCTA) parameters combined with clinical indicators.

Methods

This retrospective study enrolled 114 patients with T2DM and non-obstructive coronary artery disease (1%–49% stenosis) who underwent CCTA at our hospital between September 2019 and September 2024. After follow-up of 1–5 years, patients were stratified into a progression group (n = 48) and a control group (n = 66). Progression was defined as the occurrence of acute myocardial infarction, revascularization, or stenosis progression to ≥ 50% on follow-up CCTA. Clinical data and AI-derived quantitative parameters of pericoronary adipose tissue(PCAT) and coronary plaques were compared. A predictive model was then developed using stepwise logistic regression and its performance evaluated.

Results

The progression group had significantly higher glycated hemoglobin (HbA1c) and troponin, and lower high-density lipoprotein cholesterol (HDL-C) (all P < 0.05).CCTA analysis revealed that the progression group had a significantly greater pericoronary fat attenuation index around the left anterior descending (LAD-FAI) and left circumflex (LCX-FAI) arteries, as well as increased plaque length, total plaque volume, and specific plaque component volumes (all P < 0.05). Multivariate logistic regression analysis identified HbA1c, LAD-FAI, and plaque length as independent predictors of progression. A nomogram based on these predictors achieved an AUC of 0.8332.

Conclusion

LAD-FAI and plaque length and HbA1c are independent predictors for the progression of non-obstructive coronary lesions in T2DM patients. The proposed nomogram may provide a noninvasive and cost-effective tool for early risk stratification and preventive management.

基于ai衍生的CCTA参数和临床因素预测2型糖尿病冠状动脉粥样硬化进展:一项随访研究
目的:建立基于人工智能(AI)衍生冠状动脉ct血管造影(CCTA)参数结合临床指标的2型糖尿病(T2DM)患者冠状动脉粥样硬化进展预测模型。方法:本回顾性研究纳入了2019年9月至2024年9月在我院接受CCTA治疗的114例T2DM合并非阻塞性冠状动脉疾病(1%-49%狭窄)患者。随访1 ~ 5年,将患者分为进展组(n = 48)和对照组(n = 66)。进展定义为发生急性心肌梗死、血运重建术或随访CCTA时狭窄进展至≥50%。比较临床数据和人工智能衍生的冠状动脉周围脂肪组织(PCAT)和冠状动脉斑块的定量参数。然后利用逐步逻辑回归建立了预测模型并对其性能进行了评估。结果:进展组糖化血红蛋白(HbA1c)和肌钙蛋白显著升高,高密度脂蛋白胆固醇(HDL-C)显著降低(均为P)。结论:LAD-FAI、斑块长度和HbA1c是T2DM患者非阻塞性冠状动脉病变进展的独立预测因子。所提出的nomographic可能为早期风险分层和预防性管理提供一种无创且经济有效的工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Diabetologica
Acta Diabetologica 医学-内分泌学与代谢
CiteScore
7.30
自引率
2.60%
发文量
180
审稿时长
2 months
期刊介绍: Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书